Ingevity Corporation
NGVT
$55.50
$1.643.05%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 365.10M | 284.00M | 298.80M | 376.90M | 390.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 365.10M | 284.00M | 298.80M | 376.90M | 390.60M |
| Cost of Revenue | 227.20M | 170.60M | 190.60M | 247.00M | 267.40M |
| Gross Profit | 137.90M | 113.40M | 108.20M | 129.90M | 123.20M |
| SG&A Expenses | 44.20M | 43.10M | 39.30M | 38.70M | 41.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | 3.10M |
| Total Operating Expenses | 279.20M | 221.40M | 237.20M | 292.40M | 319.20M |
| Operating Income | 85.90M | 62.60M | 61.60M | 84.50M | 71.40M |
| Income Before Tax | -142.70M | 26.80M | 8.80M | -137.90M | -334.60M |
| Income Tax Expenses | 3.80M | 6.30M | -7.80M | -30.70M | -50.90M |
| Earnings from Continuing Operations | -146.50M | 20.50M | 16.60M | -107.20M | -283.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -146.50M | 20.50M | 16.60M | -107.20M | -283.70M |
| EBIT | 85.90M | 62.60M | 61.60M | 84.50M | 71.40M |
| EBITDA | 109.10M | 85.10M | 94.30M | 108.30M | 98.70M |
| EPS Basic | -4.02 | 0.56 | 0.46 | -2.95 | -7.81 |
| Normalized Basic EPS | 1.14 | 0.69 | 0.63 | 1.07 | 0.44 |
| EPS Diluted | -4.02 | 0.56 | 0.45 | -2.95 | -7.81 |
| Normalized Diluted EPS | 1.14 | 0.69 | 0.63 | 1.07 | 0.44 |
| Average Basic Shares Outstanding | 36.46M | 36.38M | 36.30M | 36.35M | 36.34M |
| Average Diluted Shares Outstanding | 36.46M | 36.66M | 36.60M | 36.35M | 36.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |